Laboratory measurements of sea ice: connections to microwave remote sensing

Journal ArticleThe connections between laboratory measurements and remote-sensing observations of sea ice are explored. The focus of this paper is on thin ice, which is more easily simulated in a laboratory environment. We summarize results of C-band scatterometer measurements and discuss how they may help in the interpretation of remote-sensing data. We compare the measurements with observations of thin ice from ERS and airborne radar data sets. We suggest that laboratory backscatter signatures should serve as bounds on the interpretation of remote-sensing data. We examine these bounds from the perspective of thin ice signatures, the effect of temperature, and surface processes, such as frost flowers and slush on these signatures. Controlled experiments also suggest new directions in remote-sensing measurements. The potential of polarimetric radar measurements in the retrieval of thickness of thin ice is discussed. In addition to the radar results, we discuss the importance of low-frequency passive measurements with respect to the thickness of thin ice

Enhanced Eddy Activity in the Beaufort Gyre in Response to Sea Ice Loss

The Beaufort Gyre freshwater content has increased since the 1990s, potentially stabilizing in recent years. The mechanisms proposed to explain the stabilization involve either mesoscale eddy activity that opposes Ekman pumping or the reduction of Ekman pumping due to reduced sea ice?ocean surface stress. However, the relative importance of these mechanisms is unclear. Here, we present observational estimates of the Beaufort Gyre mechanical energy budget and show that energy dissipation and freshwater content stabilization by eddies increased in the late-2000s. The loss of sea ice and acceleration of ocean currents after 2007 resulted in enhanced mechanical energy input but without corresponding increases in potential energy storage. To balance the energy surplus, eddy dissipation and its role in gyre stabilization must have increased after 2007. Our results imply that declining Arctic sea ice will lead to an increasingly energetic Beaufort Gyre with eddies playing a greater role in its stabilization

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis.

IntroductionTofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib monotherapy was previously shown to inhibit structural damage, reduce clinical signs and symptoms of RA, and improve physical functioning over 24 months in methotrexate (MTX)-naive adult patients with RA. In this post hoc analysis, we compared efficacy and safety of tofacitinib in patients with early (disease duration <1 year) versus established (≥1 year) RA.MethodsMTX-naive patients ≥18 years with active RA received tofacitinib monotherapy (5 or 10 mg two times a day, or MTX monotherapy, in a 24-month Phase 3 trial.ResultsOf 956 patients (tofacitinib 5 mg two times a day, n=373; tofacitinib 10 mg two times a day, n=397; MTX, n=186), 54% had early RA. Baseline disease activity and functional disability were similar in both groups; radiographic damage was greater in patients with established RA. At month 24, clinical response rates were significantly greater in patients with early versus established RA in the tofacitinib 5 mg two times a day group. Both tofacitinib doses had greater effects on clinical, functional and radiographic improvements at 1 and 2 years compared with MTX, independent of disease duration. No new safety signals were observed.ConclusionsTreatment response was generally similar in early and established RA; significantly greater improvements were observed at month 24 with tofacitinib 5 mg two times a day in early versus established RA. Tofacitinib 5 and 10 mg two times a day demonstrated greater efficacy versus MTX irrespective of disease duration. No difference in safety profiles was observed between patients with early or established RA.Trial registration numberNCT01039688; Results

Drosophila fasciclinII Is Required for the Formation of Odor Memories and for Normal Sensitivity to Alcohol

AbstractDrosophila fasciclinII (fasII) mutants perform poorly after olfactory conditioning due to a defect in encoding, stabilizing, or retrieving short-term memories. Performance was rescued by inducing the expression of a normal transgene just before training and immediate testing. Induction after training but before testing failed to rescue performance, showing that Fas II does not have an exclusive role in memory retrieval processes. The stability of odor memories in fasII mutants are indistinguishable from control animals when initial performance is normalized. Like several other mutants deficient in odor learning, fasII mutants exhibit a heightened sensitivity to ethanol vapors. A combination of behavioral and genetic strategies have therefore revealed a role for Fas II in the molecular operations of encoding short-term odor memories and conferring alcohol sensitivity. The preferential expression of Fas II in the axons of mushroom body neurons furthermore suggests that short-term odor memories are formed in these neurites

p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

Suppression of apoptosis by TP53 mutation contributes to resistance of acute myeloid leukemia (AML) to conventional cytotoxic treatment. Using differentiation to induce irreversible cell cycle exit in AML cells could be a p53-independent treatment alternative, however, this possibility requires evaluation. In vitro and in vivo regimens of the cytosine analogue decitabine that deplete the chromatin modifying enzyme DNA methyl-transferase 1 (DNMT1) without phosphorylating p53 or inducing early apoptosis were determined. These decitabine regimens but not equimolar DNA-damaging cytarabine up regulated the key late differentiation factors CEBPε and p27/CDKN1B, induced cellular differentiation, and terminated AML cell-cycle, even in cytarabine-resistant p53- and p16/CDKN2A-null AML cells. Leukemia initiation by xeno-transplanted AML cells was abrogated but normal hematopoietic stem cell (HSC) engraftment was preserved. In vivo, the low toxicity allowed frequent drug administration to increase exposure, an important consideration for S-phase specific decitabine therapy. In xeno-transplant models of p53-null and relapsed/refractory AML, the non-cytotoxic regimen significantly extended survival compared to conventional cytotoxic cytarabine. Modifying in vivo dose and schedule to emphasize this pathway of decitabine action can bypass a mechanism of resistance to standard therapy

MRI-based visual and haptic catheter feedback: simulating a novel system's contribution to efficient and safe MRI-guided cardiac electrophysiology procedures

Oral Presentationpublished_or_final_versio

Fluctuating Atlantic inflows modulate Arctic atlantification

Enhanced warm, salty subarctic inflows drive high-latitude atlantification, which weakens oceanic stratification, amplifies heat fluxes, and reduces sea ice. In this work, we show that the atmospheric Arctic Dipole (AD) associated with anticyclonic winds over North America and cyclonic winds over Eurasia modulates inflows from the North Atlantic across the Nordic Seas. The alternating AD phases create a “switchgear mechanism.” From 2007 to 2021, this switchgear mechanism weakened northward inflows and enhanced sea-ice export across Fram Strait and increased inflows throughout the Barents Sea. By favoring stronger Arctic Ocean circulation, transferring freshwater into the Amerasian Basin, boosting stratification, and lowering oceanic heat fluxes there after 2007, AD+ contributed to slowing sea-ice loss. A transition to an AD− phase may accelerate the Arctic sea-ice decline, which would further change the Arctic climate system.acceptedVersio

Population Synthesis of Common Envelope Mergers: I. Giant Stars with Stellar or Substellar Companions

Using a population synthesis technique, we have calculated detailed models of the present-day field population of objects that have resulted from the merger of a giant primary and a main-sequence or brown dwarf secondary during common-envelope evolution. We used a grid of 116 stellar and 32 low-mass/brown dwarf models, a crude model of the merger process, and followed the angular momentum evolution of the binary orbit and the primary's rotation prior to merger, as well as the merged object's rotation after the merger. We find that present-day merged objects that are observable as giant stars or core-helium burning stars in our model population constitute between 0.24% and 0.33% of the initial population of ZAMS binaries, depending upon the input parameters chosen. The median projected rotational velocity of these merged objects is ~16 km/sec, an order of magnitude higher than the median projected rotational velocity in a model population of normal single stars calculated using the same stellar models and initial mass function. The masses of the merged objects are typically less than ~2 solar masses, with a median mass of 1.28 solar masses, which is slightly more than, but not significantly different from, their normal single star counterparts. The luminosities in our merged object population range from ~10-100 solar luminosities, with a strong peak in the luminosity distribution at ~60 solar luminosities, since the majority of the merged objects (57%) lie on the horizontal branch at the present epoch. The results of our population synthesis study are discussed in terms of possible observational counterparts either directly involving the high rotational velocity of the merger product or indirectly, via the effect of rotation on envelope abundances and on the amount and distribution of circumstellar matter.Comment: 16 pages, 12 figures, accepted for publication in the Astrophysical Journa

Snow Property Controls on Modeled Ku-Band Altimeter Estimates of First-Year Sea Ice Thickness: Case Studies From the Canadian and Norwegian Arctic

Uncertainty in snow properties impacts the accuracy of Arctic sea ice thickness estimates from radar altimetry. On first-year sea ice (FYI), spatiotemporal variations in snow properties can cause the Ku-band main radar scattering horizon to appear above the snow/sea ice interface. This can increase the estimated sea ice freeboard by several centimeters, leading to FYI thickness overestimations. This article examines the expected changes in Ku-band main scattering horizon and its impact on FYI thickness estimates, with variations in snow temperature, salinity, and density derived from ten naturally occurring Arctic FYI Cases encompassing saline/nonsaline, warm/cold, simple/complexly layered snow (4–45 cm) overlying FYI (48–170 cm). Using a semi-empirical modeling approach, snow properties from these Cases are used to derive layer-wise brine volume and dielectric constant estimates, to simulate the Ku-band main scattering horizon and delays in radar propagation speed. Differences between modeled and observed FYI thickness are calculated to assess sources of error. Under both cold and warm conditions, saline snow covers are shown to shift the main scattering horizon above from the snow/sea ice interface, causing thickness retrieval errors. Overestimates in FYI thicknesses of up to 65% are found for warm, saline snow overlaying thin sea ice. Our simulations exhibited a distinct shift in the main scattering horizon when the snow layer densities became greater than 440 kg/m 3 , especially under warmer snow conditions. Our simulations suggest a mean Ku-band propagation delay for snow of 39%, which is higher than 25%, suggested in previous studies

Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB1*0401+ Patients With Renal Cell Carcinoma or Melanoma

T helper type 1 (Th1)-type CD4+ antitumor T cell help appears critical to the induction and maintenance of antitumor cytotoxic T lymphocyte (CTL) responses in vivo. In contrast, Th2- or Th3/Tr-type CD4+ T cell responses may subvert Th1-type cell-mediated immunity, providing a microenvironment conducive to disease progression. We have recently identified helper T cell epitopes derived from the MAGE-6 gene product; a tumor-associated antigen expressed by most melanomas and renal cell carcinomas. In this study, we have assessed whether peripheral blood CD4+ T cells from human histocompatibility leukocyte antigens (HLA)-DRβ1*0401+ patients are Th1- or Th2-biased to MAGE-6 epitopes using interferon (IFN)-γ and interleukin (IL)-5 enzyme-linked immunospot assays, respectively. Strikingly, the vast majority of patients with active disease were highly-skewed toward Th2-type responses against MAGE-6–derived epitopes, regardless of their stage (stage I versus IV) of disease, but retained Th1-type responses against Epstein-Barr virus– or influenza-derived epitopes. In marked contrast, normal donors and cancer patients with no current evidence of disease tended to exhibit either mixed Th1/Th2 or strongly Th1-polarized responses to MAGE-6 peptides, respectively. CD4+ T cell secretion of IL-10 and transforming growth factor (TGF)-β1 against MAGE-6 peptides was not observed, suggesting that specific Th3/Tr-type CD4+ subsets were not common events in these patients. Our data suggest that immunotherapeutic approaches will likely have to overcome or complement systemic Th2-dominated, tumor-reactive CD4+ T cell responses to provide optimal clinical benefit